F THANDROYEN

1.1k total citations
45 papers, 859 citations indexed

About

F THANDROYEN is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, F THANDROYEN has authored 45 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 14 papers in Molecular Biology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in F THANDROYEN's work include Cardiac electrophysiology and arrhythmias (26 papers), Cardiac Ischemia and Reperfusion (8 papers) and Ion channel regulation and function (6 papers). F THANDROYEN is often cited by papers focused on Cardiac electrophysiology and arrhythmias (26 papers), Cardiac Ischemia and Reperfusion (8 papers) and Ion channel regulation and function (6 papers). F THANDROYEN collaborates with scholars based in South Africa, United States and Germany. F THANDROYEN's co-authors include Lionel H. Opie, L. Maximilian Buja, Andrew O. Wheatley, Karen P. Burton, Joy McCarthy, Michael Worthington, Herbert K. Hagler, James T. Willerson, A S Mitha and Bruce D. Ziman and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

F THANDROYEN

44 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F THANDROYEN South Africa 15 580 362 213 110 101 45 859
Andre Terzic United States 10 251 0.4× 270 0.7× 255 1.2× 163 1.5× 49 0.5× 12 754
Christopher Reithmann Germany 19 798 1.4× 282 0.8× 57 0.3× 100 0.9× 104 1.0× 82 1.1k
Masato Tani Japan 11 310 0.5× 257 0.7× 348 1.6× 47 0.4× 71 0.7× 20 659
Hiroharu Funaya Japan 13 480 0.8× 163 0.5× 324 1.5× 90 0.8× 55 0.5× 19 938
Stanley R. Jolly United States 13 349 0.6× 137 0.4× 191 0.9× 167 1.5× 23 0.2× 31 716
Heng-Jie Cheng United States 14 554 1.0× 311 0.9× 120 0.6× 63 0.6× 54 0.5× 28 827
Francis L. Belloni United States 16 392 0.7× 148 0.4× 232 1.1× 134 1.2× 46 0.5× 35 878
M Tani Japan 11 588 1.0× 362 1.0× 662 3.1× 41 0.4× 75 0.7× 23 1.0k
Che‐Ping Cheng United States 23 1.1k 2.0× 379 1.0× 135 0.6× 110 1.0× 69 0.7× 34 1.5k
S Grasso Italy 6 295 0.5× 160 0.4× 118 0.6× 71 0.6× 40 0.4× 16 629

Countries citing papers authored by F THANDROYEN

Since Specialization
Citations

This map shows the geographic impact of F THANDROYEN's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F THANDROYEN with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F THANDROYEN more than expected).

Fields of papers citing papers by F THANDROYEN

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F THANDROYEN. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F THANDROYEN. The network helps show where F THANDROYEN may publish in the future.

Co-authorship network of co-authors of F THANDROYEN

This figure shows the co-authorship network connecting the top 25 collaborators of F THANDROYEN. A scholar is included among the top collaborators of F THANDROYEN based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F THANDROYEN. F THANDROYEN is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
THANDROYEN, F, et al.. (1998). Expanding the phenotype of the 8344 transfer RNA lysine mitochondrial DNA mutation. Neurology. 51(5). 1447–1450. 42 indexed citations
2.
THANDROYEN, F, et al.. (1996). Intra-aortic Thrombus Producing Embolic Arterial Vascular Disease. Circulation. 93(7). 1471–1471. 7 indexed citations
3.
THANDROYEN, F, et al.. (1991). Intracellular calcium transients and arrhythmia in isolated heart cells.. Circulation Research. 69(3). 810–819. 96 indexed citations
4.
Worthington, Michael, et al.. (1990). Antiarrhythmic and Metabolic Effects of Indoramin During Acute Regional Ischemia and Reperfusion in Isolated Rat Heart. Journal of Cardiovascular Pharmacology. 15(3). 408–413. 2 indexed citations
5.
Taylor, Anne L., Rachel W. Winter, F THANDROYEN, et al.. (1990). Potentiation of reperfusion-associated ventricular fibrillation by left ventricular hypertrophy.. Circulation Research. 67(2). 501–509. 11 indexed citations
6.
Opie, Lionel H., et al.. (1989). Critical Role of Dose in Protection by Propranolol Against Ventricular Fibrillation in a Pig Model of Acute Myocardial Ischemia. Journal of Cardiovascular Pharmacology. 13(2). 192–197. 10 indexed citations
7.
Shapiro, William, Kenneth A. Narahara, John B. Kostis, F THANDROYEN, & Lenore R. Zohman. (1989). Comparison of atenolol and nifedipine in chronic stable angina pectoris. The American Journal of Cardiology. 64(3). 186–190. 14 indexed citations
8.
Opie, Lionel H., William A. Coetzee, S C Dennis, & F THANDROYEN. (1988). A Potential Role of Calcium Ions in Early Ischemic and Reperfusion Arrhythmias. Annals of the New York Academy of Sciences. 522(1). 464–477. 42 indexed citations
10.
THANDROYEN, F, et al.. (1987). Arrhythmogenic action of α1-adrenoceptor stimulation in normoxic rat ventricular myocardium: Influence of nisoldipine, reduced extracellular Ca2+ and ryanodine. Journal of Molecular and Cellular Cardiology. 19(9). 841–851. 9 indexed citations
11.
THANDROYEN, F, et al.. (1985). Arrhythmogenic action of alpha1 adrenoceptor stimulation in isolated non-ligated rat heart. Journal of Molecular and Cellular Cardiology. 17. 5–5. 2 indexed citations
12.
THANDROYEN, F, et al.. (1984). MOLECULAR AND BIOCHEMICAL MECHANISMS UNDERLYING THE ROLE OF CALCIUM IONS IN MALIGNANT VENTRICULAR ARRHYTHMIAS. Annals of the New York Academy of Sciences. 427(1). 127–139. 10 indexed citations
13.
THANDROYEN, F, et al.. (1983). The effect of alpha- and beta-adrenoceptor antagonist agents on reperfusion ventricular fibrillation and metabolic status in the isolated perfused rat heart. Journal of the American College of Cardiology. 1(4). 1056–1066. 70 indexed citations
15.
THANDROYEN, F, Michael Worthington, & Lionel H. Opie. (1982). Combined α- and β-adrenoceptor antagonism protects against reperfusion ventricular arrhythmias. The American Journal of Cardiology. 49(4). 913–913. 1 indexed citations
16.
THANDROYEN, F, et al.. (1981). Penetrating thoracic trauma producing cardiac shunts. Journal of Thoracic and Cardiovascular Surgery. 81(4). 569–573. 35 indexed citations
17.
Hamm, Christian W., F THANDROYEN, & Lionel H. Opie. (1981). Protection of ischemic myocardium by diltiazem. The American Journal of Cardiology. 47. 442–442. 2 indexed citations
18.
THANDROYEN, F, et al.. (1981). Protection against ventricular fibrillation by calcium antagonists. The American Journal of Cardiology. 47. 438–438. 7 indexed citations
19.
THANDROYEN, F, et al.. (1980). Severe calcification of glutaraldehyde-preserved porcine xenografts in children. The American Journal of Cardiology. 45(3). 690–696. 76 indexed citations
20.
THANDROYEN, F, et al.. (1978). Severe aortic incompetence caused by systemic lupus erythematosus. A case report.. PubMed. 54(4). 166–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026